Dr. Adler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 Plymouth Rd
NCRC Building 16, G029W
Ann Arbor, MI 48109Phone+1 734-615-0398
Summary
- I am a pediatric gastroenterologist and health services researcher at the University of Michigan. My clinical and research interest is in the care of children and adolescents with Crohn's disease and ulcerative colitis (inflammatory bowel disease). My research focus is on developing strategies to individualize patient care to improve short-term and long-term outcomes, prevent disease-related complications, and improve health related quality of life. I am a strong believer in high-quality science, and equitable access to high-quality care for all.
Education & Training
- Cincinnati Children's Hospital Medical CenterAdvanced Improvement Methods Certificate, 2009 - 2010
- University of MichiganMSc, Health and Health Care Research, 2008 - 2009
- University of MichiganFellowship, Pediatric Gastroenterology, 2005 - 2008
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1994 - 1997
- University of South Florida College of MedicineClass of 1994
Certifications & Licensure
- MI State Medical License 2005 - 2027
- NY State Medical License 1997 - 2006
- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- Best Physician as Chosen by Their Peers 14th Annual Top Docs Issue, Hour Detroit Magazine
- Best Physician as Chosen by Their Peers 13th Annual Top Docs Issue, Hour Detroit Magazine
- Best Physician as Chosen by Their Peers 12th Annual Top Docs Issue, Hour Detroit Magazine
- Join now to see all
Clinical Trials
- Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy Start of enrollment: 2016 Oct 01
Publications & Presentations
PubMed
- 49 citationsTransition readiness in pediatric patients with inflammatory bowel disease: patient survey of self-management skills.Emily P. Whitfield, Emily M. Fredericks, Sally J. Eder, Benjamin H. Shpeen, Jeremy Adler
Journal of Pediatric Gastroenterology and Nutrition. 2015-01-01 - 17 citationsMagnetization transfer in lamellar liquid crystalsDariya I. Malyarenko, Ellen M. Zimmermann, Jeremy Adler, Scott D. Swanson
Magnetic Resonance in Medicine. 2014-11-01 - 30 citationsFactors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases.Michael D Kappelman, Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Runa Watkins
The American Journal of Gastroenterology. 2022-03-01
Press Mentions
- Early Anti-TNF Treatment Pivotal in Preventing Perianal Fistula in Pediatric Crohn’s DiseaseJune 19th, 2024
- The Impact of Quality of Care in Patients with Pediatric IBDFebruary 15th, 2024
- Early Anti-TNF Reduces Perianal Fistula Risk in Kids With Crohn'sJanuary 28th, 2024
- Join now to see all
Grant Support
- Standardization of evaluation and management of pediatric perianal Crohn’s disease to improve outcomes through networking (SETON)National Institutes of Health / National Institute of Diabetes and Digestive and Kidney Diseases2023–2028
- Creating a Brighter Future for Children with Crohn’s DiseaseKripke Crohn’s Disease Research Award2023–2024
- Research on the prevention of fistulas and strictures among Children with Crohn’s DiseaseShaevsky Family Research Fund for Crohn’s Disease2022–2024
- Targeted therapy for pediatric Crohn’s disease: Tissue levels of medications and cytokinesCharles Woodson Collaborative Research Award2022–2024
- Validation of Physician Global Assessment of Colonoscopy for Pediatric Crohn’s DiseasePediatric Research Organization for Kids with Intestinal Inflammatory Disorders (PROKIIDS)2017–Present
- Predicting anti-drug antibodies and treatment failureThe Gary and Rachel Glick Charitable Fund2020–2023
- Real-world Evidence for the Effectiveness and Safety of Ustekinumab Treatment in Children with Crohn’s Disease: A Retrospective Cohort Study using the ImproveCareNow Registry DataJanssen Research & Development, LLC.2020–2023
- Evaluating the Comparative Effectiveness of Medical Therapy for Prevention of Intestinal Fistula Development in Pediatric Crohn’s DiseaseNational Institutes of Health / National Institute of Diabetes and Digestive and Kidney Diseases2017–2019
- Customized Daily Symptom Monitoring to Improve Symptoms and Individualize Treatment Efficacy in Pediatric Inflammatory Bowel DiseaseCrohn’s and Colitis Foundation of America2014–2016
- Identifying Fistulizing Crohn’s Disease from Administrative ClaimsBlue Cross Blue Shield of Michigan Foundation2013–2016
- Advancing Child Health through Cellular and Molecular BiologyNational Institutes of Health / National Institute of Child Health and Human Development2008–2011
Committees
- Member, Impact methodology consulting team, Crohn’s & Colitis Foundation 2023 - Present
- Co-Chair, Research Committee, ImproveCareNow Network 2021 - Present
- Chair, Pragmatic Clinical Research workgroup, Challenges in IBD 2024, Crohn’s & Colitis Foundation 2023 - 2024
- Chair, Inflammatory Bowel Disease Committee, North American Society for Pediatric Gastroenterology Hepatology and Nutrition (NASPGHAN) 2022 - 2024
- Chair, Clinical Research Investigator Awards Review Committee, National Scientific Advisory Committee (NSAC) cabinet, Crohn’s & Colitis Foundation 2021 - 2024
- Member, Role of Biomarkers for Inflammatory Bowel Disease, AGA Clinical Guidelines Committee, Invited Technical Review Expert 2021 - 2024
- Vice-Chair, Vice Chair, Inflammatory Bowel Disease Committee, North American Society for Pediatric Gastroenterology Hepatology and Nutrition (NASPGHAN) 2020 - 2022
- Co-Chair, Clinical Research Awards Committee, National Scientific Advisory Committee (NSAC) cabinet, Crohn’s & Colitis Foundation 2018 - 2021
- Invited voting member, Arthritis Advisory Committee (AAC), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) 2016 - 2016
- Member, Pediatric Affairs Committee, National Scientific Advisory Committee, Crohn's & Colitis Foundation of America 2015 - 2017
- Member, Inflammatory Bowel Disease Committee, North American Society for Pediatric Gastroenterology Hepatology and Nutrition (NASPGHAN) 2013 - 2016
- Member, Clinical Committee, ImproveCareNow Network 2012 - 2021
- Member, Research Committee, ImproveCareNow Network 2011 - 2013
Professional Memberships
- Member
- North American Society for Pediatric Gastroenterology, Hepatology and NutritionMember
- Crohn's and Colitis FoundationMember
- ImproveCareNow NetworkMember
- Fellow
- European Crohn’s and Colitis Organisation (ECCO)Member
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: